Dr. Lastra is a surgical pathologist and cytopathologist with subspecialty focus in gynecologic pathology.
The Johns Hopkins Hospital
Advanced Specialty Training Program - Gynecologic Pathology
2015
Hospital of the University of Pennsylvania
Fellowship - Cytopathology
2014
Hospital of the University of Pennsylvania
Fellowship - Surgical Pathology
2013
Pennsylvania Hospital
Residency - Anatomic and Clinical Pathology
2012
Universidad Central de Venezuela
MD
2005
Integration of cell-type resolved spatial proteomics and transcriptomics reveals novel mechanisms in early ovarian cancer.
Integration of cell-type resolved spatial proteomics and transcriptomics reveals novel mechanisms in early ovarian cancer. medRxiv. 2025 Aug 28.
PMID: 40909841
Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer.
Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer. Breast Cancer Res Treat. 2025 Oct; 213(3):347-354.
PMID: 40779028
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression.
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression. Cancer Cell. 2025 Aug 11; 43(8):1495-1511.e7.
PMID: 40578359
A Proteogenomic View of Synchronous Endometrioid Endometrial and Ovarian Cancer.
A Proteogenomic View of Synchronous Endometrioid Endometrial and Ovarian Cancer. Clin Cancer Res. 2025 Jun 03; 31(11):2230-2240.
PMID: 40145935
Adaptive immune response and PD-1/ PD-L1 status in chemotherapy treated high grade serous carcinoma is dependent on chemotherapy response score.
Adaptive immune response and PD-1/ PD-L1 status in chemotherapy treated high grade serous carcinoma is dependent on chemotherapy response score. Hum Pathol. 2025 May; 159:105800.
PMID: 40389122
Clinicopathologic and Molecular Characterization of Gynecologic Carcinosarcomas With a Mesonephric-Like Carcinomatous Component.
Clinicopathologic and Molecular Characterization of Gynecologic Carcinosarcomas With a Mesonephric-Like Carcinomatous Component. Am J Surg Pathol. 2025 May 01; 49(5):439-447.
PMID: 39931796
A cell atlas of the human fallopian tube throughout the menstrual cycle and menopause.
A cell atlas of the human fallopian tube throughout the menstrual cycle and menopause. Nat Commun. 2025 01 03; 16(1):372.
PMID: 39753552
Molecular and Clinicopathologic Characterization of HER2-overexpressed Squamous Cell Carcinoma of the Cervix.
Molecular and Clinicopathologic Characterization of HER2-overexpressed Squamous Cell Carcinoma of the Cervix. Int J Gynecol Pathol. 2025 Jul 01; 44(4):323-330.
PMID: 39480104
Presence and extent of lymphovascular invasion in surgical stage I squamous cell carcinoma of the cervix: a comprehensive, international, multicentre, retrospective clinicopathological study.
Presence and extent of lymphovascular invasion in surgical stage I squamous cell carcinoma of the cervix: a comprehensive, international, multicentre, retrospective clinicopathological study. Pathology. 2025 Feb; 57(1):17-26.
PMID: 39477763
Cervical squamous cell carcinoma outcomes across continents: A retrospective study.
Cervical squamous cell carcinoma outcomes across continents: A retrospective study. Gynecol Oncol. 2024 11; 190:272-282.
PMID: 39265465